Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer

AIDS Reviews

Volumn 12, Issue 3, 2010, Pages 149-152

  Mikovits, Judy A ^a   Huang, Ying ^b   Pfost, Max A ^a   Lombardi, Vincent C ^a   Bertolette, Daniel C ^b   Hagen, Kathryn S ^a   Ruscetti, Francis W ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biological amplification; Chronic fatigue syndrome; Molecular enrichment; New retrovirus; Prostate cancer; XMRV

Indexed keywords

BLOOD CELL; BLOOD SAMPLING; CELL STIMULATION; CHRONIC FATIGUE SYNDROME; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DNA DETERMINATION; FALSE NEGATIVE RESULT; GENE AMPLIFICATION; HUMAN; MURINE LEUKEMIA VIRUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENSITIVITY ANALYSIS; VIRUS DETECTION; VIRUS INFECTION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS INFECTION; BLOOD; ENVELOPE GENE; GENETICS; ISOLATION AND PURIFICATION; MALE; PROSTATE TUMOR; STRUCTURAL GENE; VIROLOGY;

VIRUS ANTIBODY;

ANTIBODIES, VIRAL; FATIGUE SYNDROME, CHRONIC; GENES, ENV; GENES, GAG; HUMANS; LEUKEMIA VIRUS, MURINE; MALE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS;

EID: 78049490034     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Urisman A, Molinaro R, Fischer N, et al. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNA-SEL variant. PLoS Pathog. 2006;2:e25.
2. Levy J. Xenotropic viruses: murine leukemia viruses associated with NIH Swiss, NZB, and other mouse strains. Science. 1973;182:1151-3.
3. Yan Y, Liu Q, Kozak C. Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 2009;6:87.
4. Lombardi V, Ruscetti F, Das Gupta J, et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science. 2009;326:585-9.
5. Kim S, Kim N, Dong B, et al. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol. 2008;82:9964-77.
6. Arnold R, Makarova N, Osunkoya A, et al. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 2010;75:755-61.
7. Schlaberg R, Choe D, Brown K, Thaker H, Singh I. XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci USA. 2009;106:16351-6.
8. Sfanos K, Sauvageot J, Fedor H, Dick J, De Marzo A, Isaacs W. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate. 2008;68:306-20.
9. Fischer N, Hellwinkel O, Schulz C, et al. Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol. 2008;43:277-83.
10. Hohn O, Krause H, Barbarotto P, et al. Lack of evidence for xenotropic murine leukemia virus-related virus (XMRV) in German prostate cancer patients. Retrovirology 2009;6:92.
11. Dong B, Silverman R. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus. J Virol. 2010;84:1648-51.
12. Rodriguez J, Goff S. Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol. 2010;84:2556-62.
13. Mikovits J, Lombardi V, Pfost M, Hagen K, Ruscetti F. Addenda to: Detection of an infections retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Virulence. 2010;1(5):1-5.
14. Erlwein O, Kaye S, McClure M, et al. Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 2010;5:e8519.
15. Groom H, Yap M, Galao R, Neil S, Bishop K. Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci USA. 2010;107:5166-71.
16. van Kuppeveld F, de Jong A, Lanke K, et al. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010;340:c1018.
17. Switzer W, Jia H, Hohn O, et al. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States Retrovirology. 2010;7:57.
18. Alcantara L, de Oliveira T, Gordon M, et al. Tracing the origin of Brazilian HTLV-1 as determined by analysis of host and viral genes. AIDS. 2006;20:780-2.
19. Hlela C, Shepperd S, Khumalo N, Taylor G. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev 2009;11:205-14.
20. Van Dooren S, Pybus O, Salemi M, et al. The low evolutionary rate of human T-cell lymphotropic virus type-1 confirmed by analysis of vertical transmission chains. Mol Biol Evol. 2004;21:603-11.
21. Sharpe M, Archard L, Banatvala J, et al. A report - chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
22. Fukuda K, Straus S, Hickie I, Sharpe M, Dobbins J, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9. (Pubitemid 24370860)
23. Jason L, Torres-Harding S, Jurgens A, Helgerson J. Comparing the Fukuda et al. criteria and the Canadian definition for chronic fatigue syndrome. J Chron Fatigue Syndr. 2004;12: 37-52. (Pubitemid 39600524)
24. Tan E, Sugiura K, Gupta S. The case definition of chronic fatigue syndrome. J Clin Immunol. 2002;22:8-12. (Pubitemid 34203123)
25. Fischer N, Schulz C, Stieler K, et al. Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis. 2009;16:1000-2.